Agilent Technologies Inc. and the Wyss Institute for Biologically Inspired Engineering at Harvard University today announced an agreement to work together to develop innovative tools, technologies and instruments that will advance human health and improve the environment.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed working videos of its first product offering – the StemDisc450™, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
A new study by Rice University bioengineers finds that the workhorse proteins that move cargo inside living cells behave like prima donnas. The protein, called kinesin, is a two-legged molecular machine.
The governments of Australia and China have signed an agreement to further expand nanoscience research between the two countries. The governments have announced, they will jointly fund a new state-of-the-art nanotechnolo...
The Iran Nanotechnology Initiative Council (INIC) and the Venezuelan Science Ministry's Center for Science and Technology Research signed a Memorandum of Understanding (MoU) on co-operation in the field of nanotechno...
Korean Biotechnology leader AnyGen is launching its high-level custom-made and catalogue peptides for the first time in the U.S. AnyGen offers the highest purity peptide available (98% vs. 95% for most competitors).
The American molecular biologist Susan Lindquist from the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, USA, is the 2010 recipient of the Max Delbruck Medal awarded in Berlin, Germany. Lindquis...
The White House is making efforts to garner public support for its plans for a $1.8 billion research and development program aimed at broadening the applications of nanotechnology.
The National Nanotechnology Initiati...
Reiterating its presence in the world of nanotechnology, Russia announced its plans for the establishment of an indigenous, full fledged nanotechnology branch on Wednesday. The announcement came from Russian President Dm...
Spectrum Pharmaceuticals, Inc. a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has been awarded grants totaling $977,900 under the Qualifying Therapeutic Discovery Project (QTDP) Program administered under section 48D of the Internal Revenue Code.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.